Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.

Diefenbach MA, Benedict C, Miller SM, Stanton AL, Ropka ME, Wen KY, Fleisher LG, Mohamed NE, Hall SJ.

Transl Behav Med. 2018 Nov 21;8(6):876-886. doi: 10.1093/tbm/iby066.

2.

Explanation and elaboration of the Standards for UNiversal reporting of patient Decision Aid Evaluations (SUNDAE) guidelines: examples of reporting SUNDAE items from patient decision aid evaluation literature.

Hoffman AS, Sepucha KR, Abhyankar P, Sheridan S, Bekker H, LeBlanc A, Levin C, Ropka M, Shaffer V, Stacey D, Stalmeier P, Vo H, Wills C, Thomson R.

BMJ Qual Saf. 2018 May;27(5):389-412. doi: 10.1136/bmjqs-2017-006985. Epub 2018 Feb 21.

3.

Standards for UNiversal reporting of patient Decision Aid Evaluation studies: the development of SUNDAE Checklist.

Sepucha KR, Abhyankar P, Hoffman AS, Bekker HL, LeBlanc A, Levin CA, Ropka M, Shaffer VA, Sheridan SL, Stacey D, Stalmeier P, Vo H, Wills CE, Thomson R.

BMJ Qual Saf. 2018 May;27(5):380-388. doi: 10.1136/bmjqs-2017-006986. Epub 2017 Dec 21.

4.
5.

"It's Valid and Reliable" Is Not Enough: Critical Appraisal of Reporting of Measures in Trials Evaluating Patient Decision Aids.

Sepucha KR, Matlock DD, Wills CE, Ropka M, Joseph-Williams N, Stacey D, Ng C, Levin C, Lally J, Borkhoff CM, Thomson R.

Med Decis Making. 2014 Jul;34(5):560-6. doi: 10.1177/0272989X14528381. Epub 2014 Apr 8. Review.

6.

A blueprint for genomic nursing science.

Genomic Nursing State of the Science Advisory Panel, Calzone KA, Jenkins J, Bakos AD, Cashion AK, Donaldson N, Feero WG, Feetham S, Grady PA, Hinshaw AS, Knebel AR, Robinson N, Ropka ME, Seibert D, Stevens KR, Tully LA, Webb JA.

J Nurs Scholarsh. 2013 Mar;45(1):96-104. doi: 10.1111/jnu.12007. Epub 2013 Jan 31.

7.

Establishing the effectiveness of patient decision aids: key constructs and measurement instruments.

Sepucha KR, Borkhoff CM, Lally J, Levin CA, Matlock DD, Ng CJ, Ropka ME, Stacey D, Joseph-Williams N, Wills CE, Thomson R.

BMC Med Inform Decis Mak. 2013;13 Suppl 2:S12. doi: 10.1186/1472-6947-13-S2-S12. Epub 2013 Nov 29. Review.

8.

Capturing treatment decision making among patients with solid tumors and their caregivers.

Jones RA, Steeves R, Ropka ME, Hollen P.

Oncol Nurs Forum. 2013 Jan;40(1):E24-31. doi: 10.1188/13.ONF.E24-E31.

9.

Understanding the needs of women considering risk-reducing salpingo-oophorectomy.

Cherry C, Ropka M, Lyle J, Napolitano L, Daly MB.

Cancer Nurs. 2013 May-Jun;36(3):E33-8. doi: 10.1097/NCC.0b013e3182642cb5.

10.

The development and preliminary testing of a multimedia patient-provider survivorship communication module for breast cancer survivors.

Wen KY, Miller SM, Stanton AL, Fleisher L, Morra ME, Jorge A, Diefenbach MA, Ropka ME, Marcus AC.

Patient Educ Couns. 2012 Aug;88(2):344-9. doi: 10.1016/j.pec.2012.02.003. Epub 2012 Jul 7.

11.

Blogging through cancer: young women's persistent problems shared online.

Keim-Malpass J, Baernholdt M, Erickson JM, Ropka ME, Schroen AT, Steeves RH.

Cancer Nurs. 2013 Mar-Apr;36(2):163-72. doi: 10.1097/NCC.0b013e31824eb879.

PMID:
22495504
12.

Interprofessional education about decision support for patients: what are the high-priority research issues?

Lee C, McRae C, de Abreu MM, de la Torre AC, Leblanc A, Matlock D, Ropka M, Miesfeldt S.

J Interprof Care. 2011 Nov;25(6):428-30. doi: 10.3109/13561820.2011.617658. No abstract available.

PMID:
22011028
13.

Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

Ropka ME, Keim J, Philbrick JT.

J Clin Oncol. 2010 Jun 20;28(18):3090-5. doi: 10.1200/JCO.2009.27.8077. Epub 2010 May 10. Review.

14.

Health Heritage© a web-based tool for the collection and assessment of family health history: initial user experience and analytic validity.

Cohn WF, Ropka ME, Pelletier SL, Barrett JR, Kinzie MB, Harrison MB, Liu Z, Miesfeldt S, Tucker AL, Worrall BB, Gibson J, Mullins IM, Elward KS, Franko J, Guterbock TM, Knaus WA.

Public Health Genomics. 2010;13(7-8):477-91. doi: 10.1159/000294415. Epub 2010 Apr 29.

15.

Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states.

Sprangers MA, Bartels M, Veenhoven R, Baas F, Martin NG, Mosing M, Movsas B, Ropka ME, Shinozaki G, Swaab D; GENEQOL Consortium.

Qual Life Res. 2010 Dec;19(10):1429-37. doi: 10.1007/s11136-010-9652-2. Epub 2010 Apr 24. Review.

16.

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM; American Society of Clinical Oncology.

J Clin Oncol. 2009 Jul 1;27(19):3235-58. doi: 10.1200/JCO.2008.20.5179. Epub 2009 May 26.

17.

The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.

Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen NL, Ropka ME, Shi Q, Shinozaki G, Singh JA, Yang P, Zwinderman AH.

Twin Res Hum Genet. 2009 Jun;12(3):301-11. doi: 10.1375/twin.12.3.301.

18.

Mentoring nurses in familial cancer risk assessment and counseling: lessons learned from a formative evaluation.

Masny A, Ropka ME, Peterson C, Fetzer D, Daly MB.

J Genet Couns. 2008 Apr;17(2):196-207. doi: 10.1007/s10897-007-9140-1. Epub 2008 Jan 26.

PMID:
18224431
19.

Assessment of neutropenia-related quality of life in a clinical setting.

Ropka ME, Padilla G.

Oncol Nurs Forum. 2007 Mar;34(2):403-9. Review.

PMID:
17573304
20.

Uptake rates for breast cancer genetic testing: a systematic review.

Ropka ME, Wenzel J, Phillips EK, Siadaty M, Philbrick JT.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):840-55. Review.

21.

Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.

Vadaparampil ST, Ropka M, Stefanek ME.

Fam Cancer. 2005;4(2):195-206. Review.

PMID:
15951974
22.

Quality of life and chemotherapy-induced neutropenia.

Padilla G, Ropka ME.

Cancer Nurs. 2005 May-Jun;28(3):167-71. Review.

PMID:
15915058
23.

Risk modeling: applying evidence-based risk assessment in oncology nursing practice.

Ropka ME, Padilla G, Gillespie TW.

Oncol Nurs Forum. 2005 Jan 19;32(1):49-56.

PMID:
15660143
24.

Exercise manages fatigue during breast cancer treatment: a randomized controlled trial.

Mock V, Frangakis C, Davidson NE, Ropka ME, Pickett M, Poniatowski B, Stewart KJ, Cameron L, Zawacki K, Podewils LJ, Cohen G, McCorkle R.

Psychooncology. 2005 Jun;14(6):464-77.

PMID:
15484202
25.

Information needs about hereditary breast cancer among women with early-onset breast cancer.

Cohn WF, Ropka ME, Jones SM, Miesfeldt S.

Cancer Detect Prev. 2003;27(5):345-52.

PMID:
14585321
26.
27.

Breast cancer survivors' attitudes about communication of breast cancer risk to their children.

Miesfeldt S, Cohn WF, Jones SM, Ropka ME, Weinstein JC.

Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):45-50.

PMID:
12704637
28.

Symptom status and functional status outcomes: humanistic outcomes in obesity disease management.

Ropka ME.

Obes Res. 2002 Nov;10 Suppl 1:42S-49S. Review. No abstract available.

29.

Adherence to moderate-intensity exercise during breast cancer therapy.

Pickett M, Mock V, Ropka ME, Cameron L, Coleman M, Podewils L.

Cancer Pract. 2002 Nov-Dec;10(6):284-92.

PMID:
12406050
30.

Year 2000 Oncology Nursing Society Research Priorities Survey.

Ropka ME, Guterbock T, Krebs L, Murphy-Ende K, Stetz K, Summers B, Bissonette E, Given B, Mallory G.

Oncol Nurs Forum. 2002 Apr;29(3):481-91.

PMID:
11979281
31.

Treatment of urogenital atrophy with low-dose estradiol: preliminary results.

Santen RJ, Pinkerton JV, Conaway M, Ropka M, Wisniewski L, Demers L, Klein KO.

Menopause. 2002 May-Jun;9(3):179-87.

PMID:
11973441
32.

Fatigue and quality of life outcomes of exercise during cancer treatment.

Mock V, Pickett M, Ropka ME, Muscari Lin E, Stewart KJ, Rhodes VA, McDaniel R, Grimm PM, Krumm S, McCorkle R.

Cancer Pract. 2001 May-Jun;9(3):119-27.

PMID:
11879296
33.

Factors influencing patients' decisions to decline cancer genetic counseling services.

Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S.

J Genet Couns. 2001 Feb;10(1):25-40.

PMID:
11767799
34.

PRISM: Priority Symptom Management Project phase I: assessment.

Ropka ME, Spencer-Cisek P.

Oncol Nurs Forum. 2001 Nov-Dec;28(10):1585-94.

PMID:
11759306
35.

Ethical considerations in research with bereaved families.

Steeves R, Kahn D, Ropka ME, Wise C.

Fam Community Health. 2001 Jan;23(4):75-83.

PMID:
11401625
36.

Research and oncology nursing practice.

McGuire DB, Ropka ME.

Semin Oncol Nurs. 2000 Feb;16(1):35-46. Review.

PMID:
10701239
37.

A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.

Cohn DL, Fisher EJ, Peng GT, Hodges JS, Chesnut J, Child CC, Franchino B, Gibert CL, El-Sadr W, Hafner R, Korvick J, Ropka M, Heifets L, Clotfelter J, Munroe D, Horsburgh CR Jr.

Clin Infect Dis. 1999 Jul;29(1):125-33.

PMID:
10433575
38.

Establishing mechanisms to conduct multi-institutional research--fatigue in patients with cancer: an exercise intervention.

Mock V, Ropka ME, Rhodes VA, Pickett M, Grimm PM, McDaniel R, Lin EM, Allocca P, Dienemann JA, Haisfield-Wolfe ME, Stewart KJ, McCorkle R.

Oncol Nurs Forum. 1998 Sep;25(8):1391-7.

PMID:
9766292
39.

Barriers to research utilization for oncology staff nurses and nurse managers/clinical nurse specialists.

Rutledge DN, Ropka M, Greene PE, Nail L, Mooney KH.

Oncol Nurs Forum. 1998 Apr;25(3):497-506.

PMID:
9568605
40.

Body composition in clinically stable men with HIV infection.

Grady C, Ropka M, Anderson R, Lane HC.

J Assoc Nurses AIDS Care. 1996 Nov-Dec;7(6):29-38.

PMID:
9021634
41.

Use of research-based practices by oncology staff nurses.

Rutledge DN, Greene P, Mooney K, Nail LM, Ropka M.

Oncol Nurs Forum. 1996 Sep;23(8):1235-44.

PMID:
8883071
42.

Recent food intake did not influence precision of body composition estimates by bioelectrical impedance analysis in men with HIV infection.

Hayes CR, Ropka ME, Sebring NG, Anderson RE.

J Am Diet Assoc. 1996 Apr;96(4):386-8. No abstract available.

PMID:
8598442
43.

Investigating chronic symptoms in HIV: an opportunity for collaborative nursing research.

Hench K, Anderson R, Grady C, Ropka M.

J Assoc Nurses AIDS Care. 1995 May-Jun;6(3):13-7.

PMID:
7662923
44.

Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations.

Cupler EJ, Danon MJ, Jay C, Hench K, Ropka M, Dalakas MC.

Acta Neuropathol. 1995;90(1):1-6.

PMID:
7572071
45.

A comparison of calculated energy requirements to measured resting energy expenditure in HIV-1-infected subjects.

Anderson R, Grady C, Ropka M.

J Assoc Nurses AIDS Care. 1994 Nov-Dec;5(6):30-4.

PMID:
7865804
46.

The drugs 2',3'-dideoxyinosine (ddI) and 2',3'-dideoxycytidine (ddC) are safe alternatives in people with AIDS with zidovudine-induced myopathy.

Jay C, Ropka M, Dalakas MC.

J Acquir Immune Defic Syndr. 1994 Jun;7(6):630-1. No abstract available.

PMID:
8176648
47.

Disseminating research: writing abstracts.

Waller PR, Ropka ME.

J Assoc Nurses AIDS Care. 1993 Jan-Mar;4(1):58-63.

PMID:
8481503
48.

Evolving a blueprint for certification: the responsibilities and knowledge comprising American professional oncology nursing practice.

Ropka ME, Norback J, Rosenfeld M, Miller C, Nielsen B.

Oncol Nurs Forum. 1992 Jun;19(5):745-59.

PMID:
1608839
49.

Effective head and neck tumor markers. The continuing quest.

Ropka ME, Goodwin WJ, Levine PA, Sasaki CT, Kirchner JC, Cantrell RW.

Arch Otolaryngol Head Neck Surg. 1991 Sep;117(9):1011-4.

PMID:
1910716
50.

An update on nursing research and HIV infection.

Larson E, Ropka ME.

Image J Nurs Sch. 1991 Spring;23(1):4-12. Review.

PMID:
2022388

Supplemental Content

Support Center